{"id":17626,"date":"2025-05-14T13:57:23","date_gmt":"2025-05-14T11:57:23","guid":{"rendered":"https:\/\/adragos-pharma.com\/?p=17626"},"modified":"2025-05-14T14:23:15","modified_gmt":"2025-05-14T12:23:15","slug":"extractables-and-leachables-best-practices-and-key-considerations","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/extractables-and-leachables-best-practices-and-key-considerations\/","title":{"rendered":"Extractables and Leachables: Best Practices &amp; Key Considerations"},"content":{"rendered":"\n<div class=\"wp-block-rank-math-toc-block\" id=\"rank-math-toc\"><h2>Table of Contents<\/h2><nav><div><div><a href=\"#what-are-extractables-and-leachables\">What are Extractables and Leachables?<\/a><\/div><div><a href=\"#why-extractables-and-leachables-testing-is-essential\">Why Extractables and Leachables Testing is Essential<\/a><\/div><div><a href=\"#key-terminologies-defined\">Key Terminologies Defined<\/a><\/div><div><a href=\"#overview-of-regulatory-expectations\">Overview of Regulatory Expectations<\/a><\/div><div><a href=\"#packaging-in-focus-all-components-matter\">Packaging in Focus: All Components Matter<\/a><\/div><div><a href=\"#types-of-materials-and-risks-of-leaching\">Types of Materials and Risks of Leaching<\/a><\/div><div><a href=\"#analytical-techniques-for-detecting-extractables-and-leachables\">Analytical Techniques for Detecting Extractables and Leachables<\/a><\/div><div><a href=\"#quantifying-potentially-harmful-leachables\">Quantifying Potentially Harmful Leachables<\/a><\/div><div><a href=\"#extractables-and-leachables-in-various-drug-delivery-systems\">Extractables and Leachables in Various Drug Delivery Systems<\/a><\/div><div><a href=\"#planning-and-performing-extractables-and-leachables-studies\">Planning and Performing Extractables and Leachables Studies<\/a><\/div><div><a href=\"#interpreting-data-and-ensuring-safety\">Interpreting Data and Ensuring Safety<\/a><\/div><div><a href=\"#best-practice-guidelines-for-success\">Best Practice Guidelines for Success<\/a><\/div><div><a href=\"#common-challenges-in-extractables-and-leachables-projects\">Common Challenges in Extractables and Leachables Projects<\/a><\/div><div><a href=\"#trends-single-use-systems-biopharmaceuticals\">Trends: Single Use Systems &amp; Biopharmaceuticals<\/a><\/div><div><a href=\"#fa-qs-about-extractables-and-leachables\">FAQs about Extractables and Leachables<\/a><\/div><\/div><\/nav><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Within the pharmaceutical industry, development and manufacturing, patient safety goes beyond just creating effective formulas. The materials used to package and deliver those formulas\u2014from pill bottles to prefilled syringes and inhalers\u2014can interact with the medicine in complex ways. This is where the concepts of <strong>extractables and leachables (E&amp;L)<\/strong> become <strong>increasingly important<\/strong>. Recognizing and managing E&amp;L is key to making sure that unintended substances, introduced by contact with packaging materials, don\u2019t affect drug quality or pose risks to patients.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-are-extractables-and-leachables\"><strong>What are Extractables and Leachables?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Extractables<\/strong> are compounds\u2014often chemicals or tiny particles\u2014that can be pulled from packaging or container closure systems using solvents, often under laboratory-simulated \u201cworst-case\u201d or <strong>extreme conditions<\/strong> (for example, high heat or strong solvents). This simulates what could happen during the product\u2019s lifecycle, revealing <strong>potential leachables<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Leachables<\/strong> are those substances that actually migrate from the packaging, manufacturing materials, or delivery device into the drug formulation during real storage conditions or typical usage. These substances are of particular concern because, unlike extractables, leachables are directly transferred to the patient along with the drug.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Understanding the difference matters: while extractables give us an idea of what <strong>could<\/strong> get into the product under stress, leachables show us what <strong>does<\/strong> get in during normal use.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"why-extractables-and-leachables-testing-is-essential\"><strong>Why Extractables and Leachables Testing is Essential<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Identifying and controlling <strong>extractables and leachables<\/strong> is not just a regulatory box to check; it\u2019s essential for protecting patients and ensuring <strong>drug products<\/strong> are both safe and effective. Chemicals from the packaging system may contaminate the drug, potentially causing toxicity, allergic reactions, or even changing the chemical stability and efficacy of active pharmaceutical ingredients (APIs). This is especially true for complex <strong>pharmaceuticals<\/strong> like biologics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Our expert, <a href=\"https:\/\/adragos-pharma.com\/team\/marie-sophie-quittet\/\">Marie Sophie<\/a>, stated that:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><em>The sensitivity of biological products to leachables and extractables, particularly under extreme pH conditions mandated for stability or solubility, is a factor that your CDMO must consider when selecting materials. Leachables may cause conformational changes in proteins or lead to aggregation, while large-molecule drug products might chelate inorganic leachables. Such interactions can increase toxicity, reduce efficacy, or compromise stability. Thus, it is essential to thoroughly evaluate E&amp;L risks to ensure product quality and safety and to avoid costly delays in bringing a product to market.<\/em><\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">To safeguard against these issues, manufacturers carry out <strong>extractables and leachables testing<\/strong> to discover what compounds may be present, at what levels, and if they are harmful, in accordance with regulatory guidelines. This data allows manufacturers to evaluate risks, improve packaging, and avoid costly recalls or failed batches during late-stage development.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"key-terminologies-defined\"><strong>Key Terminologies Defined<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Before delving deeper, it\u2019s crucial to clarify some definitions that are core to any <strong>extractables and leachables<\/strong> discussion:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Extractables:<\/strong> Compounds that can be &#8220;pulled out&#8221; of packaging, medical devices, or manufacturing surfaces under severe, controlled laboratory conditions. This is to anticipate every possible risk.<\/li>\n\n\n\n<li><strong>Leachables:<\/strong> The subset of extractables that actually migrate into the drug (or medical device) during its real-world shelf life, storage, and use.<\/li>\n\n\n\n<li><strong>Leachable impurities:<\/strong> Unintended chemical substances that make their way into the final drug product through leaching.<\/li>\n\n\n\n<li><strong>Container closure systems:<\/strong> All the materials and components (like vials, stoppers, seals) that form the immediate packaging for a pharmaceutical product.<\/li>\n\n\n\n<li><strong>Packaging system:<\/strong> All packaging-related parts, including primary, secondary, and other associated materials, that come into contact with the drug during manufacturing, storage, and delivery.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"overview-of-regulatory-expectations\"><strong>Overview of Regulatory Expectations<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Regulatory agencies<\/strong> such as the <strong>FDA<\/strong> and equivalent organizations worldwide require pharmaceutical firms to leave nothing to chance when it comes to <strong>leachables<\/strong>. For example, the <strong>FDA<\/strong> guidance on <strong><a href=\"https:\/\/26760738.fs1.hubspotusercontent-eu1.net\/hubfs\/26760738\/social-suggested-images\/Container%20Closure%20Systems%20for%20Packaging%20Human%20Drugs%20and%20Biologics.pdf\" target=\"_blank\" rel=\"noopener\">Container Closure Systems for Packaging Human Drugs and Biologics<\/a><\/strong> notes that manufacturers must prove the safety of any material used in the packaging, processing, or delivery of drugs.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For <strong>medical devices<\/strong>, ISO standard 10993-18 outlines best practices for conducting E&amp;L assessment and risk evaluation, which pharmaceutical manufacturers must adhere to. The <strong>Product Quality Research Institute (PQRI)<\/strong>, in collaboration with the FDA, has also released influential recommendations that guide industry-wide best practices. Failing to demonstrate the safety of packaging components and materials can result in regulatory rejection, delayed approvals, or costly reformulation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"packaging-in-focus-all-components-matter\"><strong>Packaging in Focus: All Components Matter<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">When you consider a <strong>drug product\u2019s<\/strong> packaging, it\u2019s not just the bottle or vial itself that requires attention, but the entire <strong>container closure system<\/strong>. The entire <strong>packaging system<\/strong> must be evaluated for its potential to introduce <strong>extractables and leachables<\/strong>. This includes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The primary container (directly holding the drug)<\/li>\n\n\n\n<li>Any secondary packaging for added protection or labeling<\/li>\n\n\n\n<li>Clo\u00adsure materials such as stoppers, caps, seals<\/li>\n\n\n\n<li>Inks and adhesives used on labeling<\/li>\n\n\n\n<li><strong>Other packaging material<\/strong> like cartons and leaflets<\/li>\n\n\n\n<li>Manufacturing equipment (like mixers or <strong>single use systems<\/strong>)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Even trace amounts of a harmful chemical from any one of these can contaminate a batch, underscoring the importance of scrutinizing the complete system for <strong>extractable and leachable impurities<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"types-of-materials-and-risks-of-leaching\"><strong>Types of Materials and Risks of Leaching<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The types of <strong>materials<\/strong> used in <a rel=\"noopener noreferrer\" href=\"https:\/\/adragos-pharma.com\/pharmaceutical-packaging\/\" target=\"_self\">pharmaceutical <strong>packaging<\/strong><\/a>\u2014plastics, elastomers, glass, adhesives, paper, metals\u2014each come with unique properties and challenges. <strong>Chemicals<\/strong> in these materials can potentially migrate into the <strong>drug<\/strong> or product upon exposure to certain conditions. Sometimes, these substances are benign; other times, they can interfere with the active ingredients, reduce shelf life, or even cause adverse patient health outcomes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For instance, volatile organic compounds (VOCs) can evaporate and be inhaled; elemental impurities such as metals might accumulate and cause toxicity. Therefore, understanding material compatibility with both the drug and packaging is a fundamental quality concern.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"analytical-techniques-for-detecting-extractables-and-leachables\"><strong>Analytical Techniques for Detecting Extractables and Leachables<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Effectively detecting <strong>leachables<\/strong> and <strong>extractables<\/strong> involves advanced scientific techniques, which are a crucial part of extractable and leachable studies:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"a-gc-ms-gas-chromatography-mass-spectrometry\"><strong>a) GC-MS (Gas Chromatography-Mass Spectrometry)<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Essential for analyzing <strong>volatile<\/strong> and <strong>semi volatile organic compounds<\/strong>, <strong>GC-MS<\/strong> separates potential contaminants and then identifies them by their unique \u2018chemical fingerprints\u2019. This method excels at tracing both known and unknown substances at very low concentrations.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"b-lc-ms-ms-liquid-chromatography-mass-spectrometry\"><strong>b) LC-MS\/MS (Liquid Chromatography-Mass Spectrometry)<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">This powerful tool analyzes <strong>non-volatile compounds<\/strong>\u2014those that won\u2019t evaporate or break down under normal test conditions. It is especially valuable for complex or high-molecular-weight compounds, such as those often seen in <strong>biopharmaceutical products<\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"c-icp-ms-inductively-coupled-plasma-mass-spectrometry\"><strong>c) ICP-MS (Inductively Coupled Plasma-Mass Spectrometry)<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>ICP-MS<\/strong> is typically used to detect and quantify trace amounts of metals, known as <strong>elemental impurities<\/strong>. These could be introduced from glass vials, stainless steel processing equipment, or other <strong>packaging components<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These techniques are often used together to ensure a comprehensive <strong>leachables analysis<\/strong> of all possible impurity classes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"quantifying-potentially-harmful-leachables\"><strong>Quantifying Potentially Harmful Leachables<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Finding a <strong>leachable<\/strong> doesn\u2019t automatically mean it is a risk to patients, but identifying <strong>leachables extractables<\/strong> is crucial for safety assessment. Therefore, each detected <strong>compound<\/strong> is compared to an <strong>analytical evaluation threshold<\/strong> (AET)\u2014a scientifically determined level above which the compound must be evaluated for toxicity. This threshold helps focus attention and resources on substances that actually could cause harm, while minimizing unnecessary alarm over harmless low-level <strong>leachable impurities<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Professional toxicologists will assess the detected levels to determine what, if any, health risks exist, using a risk-based approach to inform further action.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"extractables-and-leachables-in-various-drug-delivery-systems\"><strong>Extractables and Leachables in Various Drug Delivery Systems<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The E&amp;L concern doesn\u2019t stop at simple bottles or blisters; devices designed for direct contact or integration with the patient\u2014like pre filled syringes, infusion pumps, inhalers, and combination products\u2014must also be carefully assessed as part of the delivery system. Here, the interaction between the drug, device, and packaging materials can be even more complex due to longer contact periods, a wider variety of materials, or storage at multiple temperatures over time.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"planning-and-performing-extractables-and-leachables-studies\"><strong>Planning and Performing Extractables and Leachables Studies<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">To assess E&amp;L risk, studies typically start with a theoretical evaluation of all <strong>components<\/strong> and <strong>materials<\/strong> that might touch the pharmaceutical product. <strong>Extractables studies<\/strong> are performed first, in which packaging or device materials are exposed to exaggerated conditions in the lab to identify the \u201cworst-case scenario\u201d of what could possibly be extracted.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Once these potential contaminants are cataloged, <strong>leachable studies<\/strong> follow, in which the finished, packaged drug is stored under real-world or accelerated conditions. Researchers use sophisticated detection methods to see which extractable compounds actually migrate into the drug over its shelf life. The resulting data is then used for a comprehensive safety risk assessment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"interpreting-data-and-ensuring-safety\"><strong>Interpreting Data and Ensuring Safety<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">After analytical tests, all results are interpreted by toxicology experts to decide whether the quantities of leachables present in pharmaceutical products could pose health concerns. In cases where an unacceptable <strong>risk<\/strong> is identified, manufacturers might switch to alternative materials, add protective barriers, adjust processing, or improve cleaning procedures of manufacturing equipment. Reassessment and retesting are vital until the <strong>pharmaceutical packaging<\/strong> is proven safe.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"best-practice-guidelines-for-success\"><strong>Best Practice Guidelines for Success<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">To minimize surprises and satisfy regulators, pharmaceutical companies should:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Begin <strong>extractables<\/strong> and <strong>leachables studies<\/strong> early in development.<\/li>\n\n\n\n<li>Choose packaging and processing <strong>materials<\/strong> proven to be compatible with drug substances.<\/li>\n\n\n\n<li>Follow guidance from recognized authorities like the PQRI, ISO, and <strong>united states pharmacopeia<\/strong>.<\/li>\n\n\n\n<li>Employ comprehensive and validated analytical methods such as <strong>GC-MS<\/strong>, <strong>LC-MS\/MS<\/strong>, and <strong>ICP-MS<\/strong>.<\/li>\n\n\n\n<li>Maintain exhaustive documentation and transparent communication with <strong>regulatory agencies<\/strong>.<\/li>\n\n\n\n<li>Assess and adjust based on changes in <strong>packaging materials<\/strong>, manufacturing processes, or <strong>single use components<\/strong>.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">By doing so, companies not only reduce regulatory surprises but also protect users from <strong>potentially harmful leachables<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"common-challenges-in-extractables-and-leachables-projects\"><strong>Common Challenges in Extractables and Leachables Projects<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Performing meticulous E&amp;L work isn\u2019t without obstacles, but there are solutions to address these challenges. For instance, advanced <strong>mass spectrometry<\/strong> data can be complicated to interpret, especially when identifying unknown substances in complex drug matrices. Matching <strong>laboratory manipulation<\/strong> results with real-world conditions demands careful study design. Changing drug formulations, moving to <strong>single use systems<\/strong>, or working with new, unfamiliar <strong>components<\/strong> can all introduce unforeseen <strong>risks<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"trends-single-use-systems-biopharmaceuticals\"><strong>Trends: Single Use Systems &amp; Biopharmaceuticals<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The rise of <strong>single use systems<\/strong> and <strong>single use products<\/strong>\u2014such as plastic bioreactors, filters, or tubing\u2014has made E&amp;L assessment even more critical. These modern manufacturing aids are convenient, but often made of complex plastics and adhesives, raising potential for extractable and leachable impurities. Biopharmaceuticals, which can be unstable and highly sensitive, face higher-than-average risk from even trace levels of packaging-derived chemicals. As such, thorough <strong>extractables and leachables testing<\/strong> in these contexts is not just best practice, but a regulatory expectation worldwide.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ensuring drug safety involves looking beyond what goes in\u2014the active and inactive pharmaceutical ingredients\u2014to what surrounds and delivers the medication. Effective <strong>extractables and leachables testing<\/strong> is essential to meeting global regulatory requirements, protecting end-users, and upholding the reputation of the pharmaceutical and medical device companies. By understanding all aspects of E&amp;L, companies can design safer products, avoid regulatory issues, and deliver the highest <strong>drug product<\/strong> quality.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-fe48e5de wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-secondary-background-color has-background wp-element-button\" href=\"https:\/\/adragos-pharma.com\/contact-us\/?utm_campaign=Banner_Blog_Articles&amp;utm_source=blog&amp;utm_medium=organic_search\">Do you want to know more about us?<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:48px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"fa-qs-about-extractables-and-leachables\"><strong>FAQs about Extractables and Leachables<\/strong><\/h2>\n\n\n\n<div class=\"wp-block-gutena-accordion gutena-accordion-block gutena-accordion-block-7dd004-84 is-layout-flow wp-block-gutena-accordion-is-layout-flow\" data-single=\"true\">\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-is-the-extractables-and-leachables-standard\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What is the extractables and leachables standard?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">No single, universal standard exists; however, industry follows the <strong>FDA<\/strong>\u2019s 1999 guidance on <strong>container closure systems for packaging human drugs<\/strong>, along with <strong>ISO 10993-18<\/strong> for medical devices, and recommendations from the <strong>Product Quality Research Institute (PQRI)<\/strong>. Many companies also use <strong>united states pharmacopeia<\/strong> chapters &lt;661&gt; and &lt;1664&gt; for current best practices in E&amp;L testing of pharmaceutical packaging and delivery systems.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-are-extractables-and-leachables-in-injectables\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What are extractables and leachables in injectables?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">In injectable products like <strong>pre filled syringes<\/strong>, <strong>extractables<\/strong> are the substances withdrawn from the <strong>packaging components<\/strong> (such as the syringe barrel, stopper, or plunger) when stressed in the lab. <strong>Leachables<\/strong> are chemicals which actually migrate into the injectable drug during storage or administration, and are thus delivered to the patient. Detecting both is essential for injectables, given their direct patient impact.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-is-extractables-testing\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What is extractables testing?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\"><strong>Extractables testing<\/strong> refers to laboratory procedures in which materials from packaging, manufacturing surfaces, or medical devices are exposed to aggressive conditions (like strong solvents, heat, etc.) to see which substances could be released and possibly pose a risk to patients. This <strong>testing<\/strong> is an important first step in risk assessment for E&amp;L.<\/p>\n<\/div><\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel gutena-accordion-block__panel\">\n<div class=\"wp-block-gutena-accordion-panel-title gutena-accordion-block__panel-title\"><div class=\"gutena-accordion-block__panel-title-inner\">\n<h3 class=\"wp-block-heading has-text-align-left\" id=\"what-is-an-e-l-test\" style=\"margin-top:0px;margin-right:0px;margin-bottom:0px;margin-left:0px\"><strong>What is an E&amp;L test?<\/strong><\/h3>\n<div class=\"trigger-up-down\"><div class=\"horizontal\"><\/div><div class=\"vertical\"><\/div><\/div><\/div><\/div>\n\n\n\n<div class=\"wp-block-gutena-accordion-panel-content gutena-accordion-block__panel-content\"><div class=\"gutena-accordion-block__panel-content-inner\">\n<p class=\"wp-block-paragraph\" style=\"margin-top:0;margin-bottom:0\">An <strong>E&amp;L (extractables and leachables) test<\/strong> is a set of scientific assessments applied to all relevant <strong>materials<\/strong> and <strong>components<\/strong> exposed to the drug, using techniques such as <strong>GC-MS<\/strong>, <strong>LC-MS\/MS<\/strong>, or <strong>ICP-MS<\/strong>. These tests <strong>identify<\/strong> and quantify any extractable or leachable impurities and provide the foundation for a toxicological risk evaluation, ensuring overall <strong>drug<\/strong> safety.<\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><\/h3>\n","protected":false},"excerpt":{"rendered":"<p>Within the pharmaceutical industry, development and manufacturing, patient safety goes beyond just creating effective formulas. The materials used to package and deliver those formulas\u2014from pill bottles to prefilled syringes and inhalers\u2014can interact with the medicine in complex ways. This is [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":14457,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[13],"tags":[],"topics":[287,35],"locations":[274],"experts":[],"class_list":["post-17626","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","topics-clinical-manufacturing","topics-packaging","locations-jura"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/17626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/comments?post=17626"}],"version-history":[{"count":3,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/17626\/revisions"}],"predecessor-version":[{"id":17631,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/17626\/revisions\/17631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media\/14457"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media?parent=17626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/categories?post=17626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/tags?post=17626"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/topics?post=17626"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/locations?post=17626"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/experts?post=17626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}